Lung mass
Pro Research Analysisby
Searched over 200M research papers for "lung mass"
Consensus Meter
The Impact of Body Mass Index (BMI) on Lung Mass and Lung Cancer Outcomes
Introduction to BMI and Lung Cancer
Body Mass Index (BMI) is a critical factor in understanding lung cancer prognosis and lung mass density. Research has shown that BMI can influence overall survival (OS) in lung cancer patients, with variations observed across different demographics such as sex, smoking status, and race .
BMI and Lung Cancer Survival
Differential Survival by Race and Sex
Studies have demonstrated that BMI's impact on lung cancer survival varies significantly by race and sex. For instance, underweight white patients with non-small cell lung cancer (NSCLC) have poorer survival rates compared to their normal-weight counterparts, while this association is not as pronounced in black patients. Additionally, female ever-smokers at the extremes of BMI (underweight or obese) tend to have worse outcomes compared to male ever-smokers.
Meta-Analysis Findings
A meta-analysis encompassing over 3 million subjects found that higher BMI is generally associated with lower lung cancer-specific mortality and all-cause mortality. Specifically, each 5 kg/m² increase in BMI was linked to a 12% reduction in lung cancer-specific mortality and a 14% reduction in all-cause mortality. This protective effect of higher BMI was more significant in Asian populations compared to Western populations.
BMI and Lung Mass Density
Predictive Models Using Machine Learning
Recent advancements in machine learning have enabled the prediction of lung mass density using non-invasive methods. For example, gradient boosting decision tree (GBDT) algorithms, such as XGBoost, have shown high accuracy in predicting lung mass density based on lung ultrasound surface wave elastography (LUSWE) and pulmonary function testing (PFT). These models can potentially offer a non-invasive alternative to traditional high-resolution computed tomography (HRCT) scans .
Lung Mass in Emphysema and Smokers
In patients with emphysema, lung mass (LM) tends to be higher than in healthy subjects, likely due to chronic inflammation and tissue remodeling. Similarly, smokers, particularly those with early-stage chronic obstructive pulmonary disease (COPD), exhibit increased lung mass, which is predictive of lung function decline over time.
BMI and Lung Volumes
Obesity significantly affects lung volumes, with the most substantial impacts observed in functional residual capacity (FRC) and expiratory reserve volume (ERV). These volumes decrease exponentially with increasing BMI, particularly in individuals with a BMI over 30 kg/m². This reduction in lung volumes can lead to respiratory symptoms and complicate the interpretation of pulmonary function tests in obese patients.
Conclusion
The relationship between BMI and lung cancer outcomes is complex and influenced by various factors, including race, sex, and smoking status. Higher BMI generally correlates with better survival rates in lung cancer patients, although this effect varies across different populations. Advances in machine learning offer promising non-invasive methods for assessing lung mass density, which is crucial for managing lung diseases such as emphysema and COPD. Understanding these relationships can help tailor more effective treatment and management strategies for lung cancer patients.
Sources and full results
Most relevant research papers on this topic